Paradigm Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-7,900
| Closed | -$72.7K | – | 551 |
|
|
2017
Q2 | $72.7K | Sell |
7,900
-8,100
| -51% | -$74.5K | 0.01% | 468 |
|
|
2017
Q1 | $137K | Sell |
16,000
-6,800
| -30% | -$58.1K | 0.03% | 455 |
|
|
2016
Q4 | $244K | Sell |
22,800
-700
| -3% | -$7.49K | 0.05% | 255 |
|
|
2016
Q3 | $255K | Buy |
23,500
+2,700
| +13% | +$29.2K | 0.04% | 304 |
|
|
2016
Q2 | $141K | Buy |
+20,800
| New | +$141K | 0.02% | 365 |
|